Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism TDP43 inhibitors(TAR DNA binding protein 43 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | Switzerland | 18 Mar 2022 |